The impact of genetic testing for Crohn's disease, risk magnitude and graphical format on motivation to stop smoking: An experimental analogue study

Clinical Genetics

Volumn 73, Issue 4, 2008, Pages 306-314

  Wright, Allison J ^a   Takeichi, C ^a   Whitwell, S C L ^a   Hankins, M ^a,b   Marteau, T M ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b BRIGHTON AND SUSSEX MEDICAL SCHOOL   (United Kingdom)

Author keywords

Communication, Crohn's disease; Genetic testing; Motivation; Risk; Smoking cessation

Indexed keywords

ADOLESCENT; ADULT; BEHAVIOR CHANGE; CIGARETTE SMOKING; CONTROLLED STUDY; CROHN DISEASE; EXPERIMENTAL STUDY; FAMILY HISTORY; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GENETIC RISK; GENETIC SUSCEPTIBILITY; HEALTH BEHAVIOR; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTIVATION; PATIENT ATTITUDE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK REDUCTION; SMOKING CESSATION; VIGNETTE;

ADULT; CROHN DISEASE; DATA DISPLAY; FAMILY HEALTH; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; INTENTION; MALE; MOTIVATION; NOD2 SIGNALING ADAPTOR PROTEIN; RISK ASSESSMENT; SMOKING CESSATION;

EID: 40749102975     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2008.00964.x     Document Type: Review

References (33)

1. Collins F, Green ED, Guttmacher AE, Guyer MS. A vision for the future of genomics research. Nature 2003: 422: 835-847.
2. Gramling R, Nash J, Siren K, Culpepper L. Predictive genetics in primary care: Expectations for the motivational impact of genetic testing affects the importance family physicians place on screening for familial cancer risk. Genet Med 2003: 5 (3): 172-175.
3. Milne S, Sheeran P, Orbell S. Prediction and intervention in health-related behavior: A meta-analytic review of protection motivation theory. J Appl Soc Psychol 2000: 30 (1): 106-143.
4. Rogers RW, Prentice-Dunn S. Protection motivation theory. In: Gochman DS, ed. Handbook of health behavior research 1: Personal and social determinants. New York, NY: Plenum, 1997: 113-132.
5. Witte K. Fear as motivator, fear as inhibitor: Using the extended parallel process model to explain fear appeal successes and failures. In: Andersen PA, Guerrero LK, eds. Handbook of communication and emotion: Research, theory, applications and contexts. New York, NY: Academic Press, 1998: 423-449.
6. Sniehotta FF, Scholz U, Schwarzer R. Bridging the intention-behaviour gap: Planning, self-efficacy, and action control in the adoption and maintenance of physical exercise. Psychol Health 2005: 20 (2): 143-160.
7. Lader D. Smoking related behaviour and attitudes, 2006. Newport: Office of National Statistics, 2007.
8. Chen S, Chaiken S. The heuristic-systematic model in its broader context. In: Chaiken S, Trope Y, eds. Dual process theories in social psychology. New York: Guilford Press, 1999: 73-96.
9. Marteau T, Senior V, Humphries SE et al. Psychological impact of genetic testing for familial hypercholesterolemia within a previously aware population: A randomized controlled trial. Am J Med Genet A 2004: 128A (3): 285-293.
10. Marteau TM, Weinman J. Self-regulation and the behavioural response to DNA risk information: A theoretical analysis and framework for future research. Soc Sci Med 2006: 62 (6): 1360-1368.
11. Chao S, Roberts JS, Marteau TM, Silliman R, Cupples LA, Green RC. Health behaviour changes after genetic risk assessment for Alzheimer's disease: the REVEAL study. Alzheimer Dis Assoc Disord 2008: (in press).
12. Ito H, Matsuo K, Wakai K et al. An intervention study of smoking cessation with feedback on genetic cancer susceptibility in Japan. Prev Med 2006: 42 (2): 102-108.
13. Audrain J, Boyd NR, Roth J, Main D, Caporaso NE, Lerman C. Genetic susceptibility testing in smoking-cessation treatment: One-year outcomes of a randomized trial. Addict Behav 1997: 22 (6): 741-751.
14. McBride CM, Bepler G, Lipkus IM et al. Incorporating genetic susceptibility feedback into a smoking cessation program for African-American smokers with low income. Cancer Epidemiol Biomarkers Prev 2002: 11 (6): 521-528.
15. Harvey-Berino J, Gold EC, West DS et al. Does genetic testing for obesity influence confidence in the ability to lose weight? A pilot investigation. J Am Diet Assoc 2001: 101 (11): 1351-1353.
16. Croyle RT, Sun YC, Louie DH. Psychological minimization of cholesterol test-results -moderators of appraisal in college-students and community residents. Health Psychol 1993: 12 (6): 503-507.
17. Croyle RT, Ditto PH. Illness cognition and behavior -an experimental approach. J Behav Med 1990: 13 (1): 31-52.
18. Ditto PH, Croyle RT. Understanding the impact of risk factor test results: Insights from a basic research program. In: Croyle RT, ed. Psychosocial effects of screening for disease prevention and detection. Kent, OH: Kent State University, 1995: 144-181.
19. Wroe AL, Salkovskis PM, Rimes KA. The effect of nondirective questioning on women's decisions whether to undergo bone density screening: An experimental study. Health Psychol 2000: 19 (2): 181-191.
20. Frosch DL, Mello P, Lerman C. Behavioral consequences of testing for obesity risk. Cancer Epidemiol Biomarkers Prev 2005: 14 (6): 1485-1489.
21. Wright AJ, French DP, Weinman J, Marteau TM. Can genetic risk information enhance motivation for smoking cessation? An analogue study. Health Psychol 2006: 25 (6): 740-752.
22. Sanderson SC, Michie S. Genetic testing for heart disease susceptibility: Potential impact on motivation to quit smoking. Clin Genet 2007: 71 (6): 501-510.
23. Ancker JS, Senathirajah Y, Kukafka R, Starren JB. Design features of graphs in health risk communication: A systematic review. J Am Med Inform Assoc 2006: 13 (6): 608-618.
24. Stone ER, Sieck WR, Bull BE, Yates JF, Parks SC, Rush CJ. Foreground: background salience: Explaining the effects of graphical displays on risk avoidance. Organ Behav Hum Decis Process 2003: 90 (1): 19-36.
25. Baty BJ, Venne V, McDonald J et al. BRCA1 testing: Genetic counseling protocol development and counseling issues. J Genet Couns 1997: 6 (2): 223-244.
26. Schapira MM, Nattinger AB, McHorney CA. Frequency or probability? A qualitative study of risk communication formats used in health care. Med Decis Making 2001: 21 (6): 459-467.
27. Hampe J, Cuthbert A, Croucher PJP et al. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet 2001: 357 (9272): 1925-1928.
28. Pascoe L, Zouali H, Sahbatou M, Hugot JP. Estimating the odds ratios of Crohn disease for the main CARD15/NOD2 mutations using a conditional maximum likelihood method in pedigrees collected via affected family members. Eur J Hum Genet 2007: 15: 864-871.
29. Hugot JP, Chamaillard M, Zouali H et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001: 411 (6837): 599-603.
30. Ogura Y, Bonen DK, Inohara N et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001: 411 (6837): 603-606.
31. Lewis C, Whitwell SCL, Forbes A, Sanderson J, Mathew CG, Marteau TM. Estimating risks for common complex diseases across genetic and environmental factors: The example of Crohn's disease. J Med Genet 2007: 44: 689-694.
32. Heatherton TF, Kozlowski LT, Frecker RC, Rickert W, Robinson J. Measuring the heaviness of smoking: Using self-reported time to the first cigarette of the day and number of cigarettes smoked per day. Br J Addict 1989: 84 (7): 791-799.
33. Goddard E. General household survey, 2005: Smoking and drinking among adults. London: Office for National Statistics, 2006.